DD202290A5 - Verfahren zur herstellung von indolderivaten - Google Patents

Verfahren zur herstellung von indolderivaten Download PDF

Info

Publication number
DD202290A5
DD202290A5 DD81235742A DD23574281A DD202290A5 DD 202290 A5 DD202290 A5 DD 202290A5 DD 81235742 A DD81235742 A DD 81235742A DD 23574281 A DD23574281 A DD 23574281A DD 202290 A5 DD202290 A5 DD 202290A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
alkyl
deep
converting
Prior art date
Application number
DD81235742A
Other languages
German (de)
English (en)
Inventor
Peter E Cross
Roger P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202290A5 publication Critical patent/DD202290A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DD81235742A 1980-12-15 1981-12-14 Verfahren zur herstellung von indolderivaten DD202290A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
DD202290A5 true DD202290A5 (de) 1983-09-07

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81235742A DD202290A5 (de) 1980-12-15 1981-12-14 Verfahren zur herstellung von indolderivaten

Country Status (22)

Country Link
US (1) US4363912A (fi)
EP (1) EP0054417B1 (fi)
JP (1) JPS57181082A (fi)
KR (1) KR830007552A (fi)
AR (1) AR229110A1 (fi)
AU (1) AU525296B2 (fi)
CA (1) CA1143737A (fi)
CS (1) CS228527B2 (fi)
DD (1) DD202290A5 (fi)
DE (1) DE3167879D1 (fi)
DK (1) DK552581A (fi)
ES (1) ES507960A0 (fi)
FI (1) FI814003L (fi)
GR (1) GR76355B (fi)
IE (1) IE51949B1 (fi)
IL (1) IL64534A0 (fi)
NO (1) NO814264L (fi)
PH (1) PH17576A (fi)
PL (1) PL133634B1 (fi)
PT (1) PT74123B (fi)
YU (1) YU293481A (fi)
ZA (1) ZA818665B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
CN1205207C (zh) * 1998-03-31 2005-06-08 药品发现学会公司 取代的吲哚链烷酸
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2001051489A2 (en) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
ES2268480T3 (es) * 2002-12-10 2007-03-16 Wyeth Derivados del acido 3-alquilo- y 3-arilalquilo-1h-indol-1-il-acetico sustituidos como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1).
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
EP2046740B1 (en) 2006-07-22 2012-05-23 Oxagen Limited Compounds having crth2 antagonist activity
BRPI0817397A2 (pt) * 2007-09-24 2015-04-07 Allergan Inc Compostos indol contendo grupos arila ou heteroarila com atividade biológica do receptor de esfingosina-1-fosfato (sip)
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
PT2250161E (pt) 2008-01-18 2014-01-21 Atopix Therapeutics Ltd Compostos tendo atividade antagonista de crth2
EP2240444A1 (en) * 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
JP2011509990A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (fi) * 1966-02-11 1967-06-19
FR7337M (fi) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
US4363912A (en) 1982-12-14
JPS57181082A (en) 1982-11-08
GR76355B (fi) 1984-08-06
IE812928L (en) 1982-06-15
FI814003L (fi) 1982-06-16
ES8308872A1 (es) 1983-10-01
DE3167879D1 (en) 1985-01-31
CA1143737A (en) 1983-03-29
AU7848881A (en) 1982-06-24
EP0054417B1 (en) 1984-12-19
AU525296B2 (en) 1982-10-28
NO814264L (no) 1982-06-16
KR830007552A (ko) 1983-10-21
AR229110A1 (es) 1983-06-15
DK552581A (da) 1982-06-16
IL64534A0 (en) 1982-03-31
PH17576A (en) 1984-10-01
IE51949B1 (en) 1987-04-29
ZA818665B (en) 1982-10-27
PT74123A (en) 1982-01-01
PL133634B1 (en) 1985-06-29
PL234253A1 (en) 1983-05-23
CS228527B2 (en) 1984-05-14
YU293481A (en) 1984-10-31
PT74123B (en) 1983-12-19
ES507960A0 (es) 1983-10-01
EP0054417A1 (en) 1982-06-23

Similar Documents

Publication Publication Date Title
DD202290A5 (de) Verfahren zur herstellung von indolderivaten
DE3008632C2 (fi)
DE3001762A1 (de) Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
CH644597A5 (de) Imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DD215546A5 (de) Verfahren zur herstellung bicyclischer thromboxansynthetase-inhibitoren
EP1198453B9 (de) N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden
EP0268148A1 (de) Tetrahydronaphthalinderivate und diese enthaltende Arzneimittel
EP0778271A2 (de) Aminoalkyl-substituierte benzo-heterocyclische Verbindungen
DE69013959T2 (de) Aminobenzolsulfonsäurederivate.
DD218890A5 (de) Verfahren zur herstellung von n-(omega-(1h-imidazol-1-yl)-alkyl)-arylamiden
DE3530046C2 (de) Äthylendiaminmonoamid-Derivate
DD202714A5 (de) Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate
DE2932967A1 (de) Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
DD149511A5 (de) Verfahren zur herstellung von 9-aminoalkylfluorenen
EP0007399B1 (de) Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE2434951B2 (de) In 3-stellung basisch substituierte diphenylhydantoine
DE3306146A1 (de) Pyridin-derivate und ihre verwendung als arzneimittel
EP0094080B1 (de) Pyrido(2,1-b)chinazolinderivate
DE69214113T2 (de) Neue Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2147882A1 (de) Triazole und tnazolhaltige Arznei mittel
WO2001007434A2 (de) Indolderivate und deren verwendung als 5ht2a liganden
EP0194579B1 (de) Neue 3-Pyridylmethylnaphthylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE68912252T2 (de) Imidazolantiarrythmische Mittel.
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE69500377T2 (de) Pyrimidin-Dion-Derivate und diese enthaltende antiarrhythmische Zusammensetzungen